Lab-on-a-chip: emerging analytical platforms for immune-mediated diseases

Unveiling the state of the art: a systematic review and meta-analysis of paper-based microfluidic devices

Introduction

This systematic review and meta-analysis present a comprehensive evaluation of paper-based microfluidic devices, focusing on their applications in immunoassays. These devices are emerging as innovative solutions to democratize access to diagnostic technologies, especially in resource-limited settings. Our review consolidates findings from diverse studies to outline advancements in paper-based microfluidic technology, including design intricacies and operational efficacy. Key advantages such as low cost, portability, and ease of use are highlighted.

Materials and Methods

The review categorizes literature based on the design and operational nuances of these diagnostic tools, exploring various methodologies, fabrication techniques, detection methods, and applications, particularly in protein science. The meta-analysis extends to the diverse applications of these technologies, providing a framework for classifying and stratifying their uses in diagnostics.

Results and discussion

Notable findings include a critical analysis of performance metrics, such as sensitivity and specificity. The review addresses challenges, including the need for further validation and optimization for broader clinical applications. A critical discussion on the validation processes, including cross-validation and rigorous control testing, is provided to ensure the robustness of microfluidic devices. This study offers novel insights into the computational strategies underpinning these technologies and serves as a comprehensive roadmap for future research, potentially broadening the impact across the protein science universe.

Light-driven peristaltic pumping by an actuating splay-bend strip

Despite spectacular progress in microfluidics, small-scale liquid manipulation, with few exceptions, is still driven by external pumps and controlled by large-scale valves, increasing cost and size and limiting complexity. By contrast, optofluidics uses light to power, control and monitor liquid manipulation, potentially allowing for small, self-contained microfluidic devices. Here we demonstrate a soft light-propelled actuator made of liquid crystal gel that pumps microlitre volumes of water. The strip of actuating material serves as both a pump and a channel leading to an extremely simple microfluidic architecture that is both powered and controlled by light. The performance of the pump is well explained by a simple theoretical model in which the light-induced bending of the actuator competes with the liquid's surface tension. The theory highlights that effective pumping requires a threshold light intensity and strip width. The proposed system explores the benefits of shifting the complexity of microfluidic systems from the fabricated device to spatio-temporal control over stimulating light patterns.

The Effect of Electro-Induced Multi-Gas Modification on Polymer Substrates’ Surface Structure for Additive Manufacturing

We investigated the effect of electro-induced multi-gas modification (EIMGM) duration on the adhesion and wear resistance of PET and LDPE polymer substrates used in the printing industry. It was found that EIMGM increases the polar component and the complete free surface energy from 26 to 57 mJ/m2 for LDPE and from 37 to 67 mJ/m2 for PET (due to the formation of oxygen-containing groups on the surface of the materials). Although the degree of textural and morphological heterogeneity of the modified LDPE increased more than twice compared to the initial state, it is not still suitable for application as a substrate in extrusion 3D printing. However, for PET, the plasma-chemical modification contributed to a significant increase (~5 times) in filament adhesion to its surface (due to chemical and morphological transformations of the surface layers) which allows for using the FFF technology for additive prototyping on the modified PET-substrates.

Microneedles for Transdermal Biosensing: Current Picture and Future Direction

A novel trend is rapidly emerging in the use of microneedles, which are a miniaturized replica of hypodermic needles with length-scales of hundreds of micrometers, aimed at the transdermal biosensing of analytes of clinical interest, e.g., glucose, biomarkers, and others. Transdermal biosensing via microneedles offers remarkable opportunities for moving biosensing technologies and biochips from research laboratories to real-field applications, and envisages easy-to-use point-of-care microdevices with pain-free, minimally invasive, and minimal-training features that are very attractive for both developed and emerging countries. In addition to this, microneedles for transdermal biosensing offer a unique possibility for the development of biochips provided with end-effectors for their interaction with the biological system under investigation. Direct and efficient collection of the biological sample to be analyzed will then become feasible in situ at the same length-scale of the other biochip components by minimally trained personnel and in a minimally invasive fashion. This would eliminate the need for blood extraction using hypodermic needles and reduce, in turn, related problems, such as patient infections, sample contaminations, analysis artifacts, etc. The aim here is to provide a thorough and critical analysis of state-of-the-art developments in this novel research trend, and to bridge the gap between microneedles and biosensors.

Biomaterials and bioengineering tomorrow's healthcare

Biomaterials are being used for the healthcare applications from ancient times. But subsequent evolution has made them more versatile and has increased their utility. Biomaterials have revolutionized the areas like bioengineering and tissue engineering for the development of novel strategies to combat life threatening diseases. Together with biomaterials, stem cell technology is also being used to improve the existing healthcare facilities. These concepts and technologies are being used for the treatment of different diseases like cardiac failure, fractures, deep skin injuries, etc. Introduction of nanomaterials on the other hand is becoming a big hope for a better and an affordable healthcare. Technological advancements are underway for the development of continuous monitoring and regulating glucose levels by the implantation of sensor chips. Lab-on-a-chip technology is expected to modernize the diagnostics and make it more easy and regulated. Other area which can improve the tomorrow’s healthcare is drug delivery. Micro-needles have the potential to overcome the limitations of conventional needles and are being studied for the delivery of drugs at different location in human body. There is a huge advancement in the area of scaffold fabrication which has improved the potentiality of tissue engineering. Most emerging scaffolds for tissue engineering are hydrogels and cryogels. Dynamic hydrogels have huge application in tissue engineering and drug delivery. Furthermore, cryogels being supermacroporous allow the attachment and proliferation of most of the mammalian cell types and have shown application in tissue engineering and bioseparation. With further developments we expect these technologies to hit the market in near future which can immensely improve the healthcare facilities.